Danaher Corporation (DHR) has attracted widespread attention from a range of investment firms in recent weeks. With a flurry of conflicting actions, including both stock buying and selling, the movements speak to the diversity of investment strategies and risk profiles in the market. A number of firms, such as
Westwood Holdings Group and
Williams Jones Wealth Management, have reduced their positions in DHR, whilst other firms like
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp and
Waverly Advisors LLC have increased their stakes. Importantly, DHR is part of Billionaire Lei Zhang's stock picks with a high upside potential. Opinions are divided on DHR’s position in bio-tech and medical stock portfolios, with a question over its risk factor. Jim Cramer’s negative views have caused some disappointment. However, DHR’s recent addition to Bill Gates’ portfolio implies strong endorsement of its potential value. Various financial moves have marked recent trading of DHR shares:
Gordian Capital Singapore Pte Ltd,
Tidal Investments LLC, and
UBS ASSET MANAGEMENT AMERICAS LLC all grew their stake in DHR. Finally, looking at Danaher's future indicators, the company has set a dividend pay-out for July 2025, signaling confidence in its continuous profitability.
Danaher Corporation DHR News Analytics from Tue, 22 Oct 2024 07:00:00 GMT to Sat, 24 May 2025 22:31:53 GMT -
Rating 5
- Innovation 6
- Information 6
- Rumor -5
